12,841 resources
Start Prev Rows 9800 - 10000 Next
Package | Version | Identity | Name/Title | Status | FMM | WG | Date | Auth | Source(s) |
---|---|---|---|---|---|---|---|---|---|
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1002.12 | Oxymorphone | active | 2022-03 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1002.70 | Morphine | active | 2024-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1002.71 | Methadone Medications | active | 2021-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1002.72 | Meperidine | active | 2024-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1002.73 | Levorphanol | active | 2021-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1002.74 | Hydromorphone | active | 2021-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1002.75 | Hydrocodone | active | 2025-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1002.76 | Fentanyl | active | 2024-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1004.12 | Butorphanol | active | 2021-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1004.15 | Opium Combinations | active | 2024-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1004.16 | Pentazocine | active | 2024-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1004.17 | Tapentadol | active | 2021-02 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1004.18 | Tramadol | active | 2024-02 | hl7 | rx | ||
hl7.fhir.us.mihr | R4 | hypertensive-disorders-pregnancy-ICD | ValueSet – Hypertensive Disorders of Pregnancy ICD | draft | 2023-03 | hl7 | icd | ||
hl7.fhir.us.mihr | R4 | hypertensive-disorders-pregnancy-SNOMED | ValueSet – Hypertensive Disorders of Pregnancy SNOMED CT | draft | 2023-03 | hl7 | sct | ||
hl7.fhir.us.eltss | R4 | eltss-observation-code | Observation Code Value Set | informative | hsswg | 2019-09 | hl7 | fhir loinc | |
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.69.6 | Planned or Completed moodCode | active | 2024-06 | hl7 | tho | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7664 | Data Elements (NND Babesiosis) | active | 2018-01 | sct oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7811 | Data Elements (CRS) | active | 2018-01 | oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7525 | Data Elements (NND CS) | active | 2018-01 | oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7663 | Data Elements (NND Malaria) | active | 2018-01 | sct oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7816 | Data Elements (Rubella) | active | 2018-01 | sct oid loinc | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7665 | Data Elements (NND Varicella) | active | 2018-01 | sct oid loinc | |||
hl7.fhir.us.pacio-toc | R4 | toc-loinc-answered-by-LL5571-6-vs | Transitions of Care LOINC Terms Answered by LL5571-6 Answer List Value Set | trial-use | 2 | pc | 2025-06 | hl7 | loinc |
hl7.fhir.us.pacio-toc | R4 | toc-del-loinc-vs | Transitions of Care DEL LOINC Terms Value Set | trial-use | 2 | pc | 2025-06 | hl7 | loinc |
hl7.fhir.us.pacio-toc | R4 | toc-del-loinc-answered-by-LL5571-6-vs | Transitions of Care LOINC Terms Included in the DEL Answered by LL5571-6 Answer List Value Set | trial-use | 2 | pc | 2025-06 | hl7 | fhir |
us.cdc.phinvads | R4 | 2.16.840.1.113883.11.20.9.38 | Current Smoking Status (NAACCR) | active | 2015-01 | sct | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1099.28 | Problem Type (LOINC) | active | 2023-07 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.39 | Result Status | active | 2024-06 | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.476 | Allergy To Vaccine Component | active | 2023-07 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1115.2 | InstructionActStatus | active | 2017-11 | hl7 | tho | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.69.7 | Obligation or Prohibition Instruction Type | active | 2017-11 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.58 | Findings Related to Medication Management, Chronic Disease Present | active | 2023-12 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.59 | Findings Related to Medication Management, Taking Medication for Chronic Disease | active | 2017-08 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.150 | Fall or Fall Risk from Wheelchair or Scooter ICD10CM | active | 2022-03 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.147 | Mobility Impairment or Fall From Chair ICD10CM | active | 2022-03 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.144 | Bed Confinement Impairment | active | 2022-03 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.302 | Test Cervical Excision Procedures | active | 2023-10 | hl7 | sct | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7449 | Qualitative Lab Result (RCMT) | active | 2016-01 | sct | |||
hl7.fhir.us.core | R4 | us-core-screening-assessment-observation-maximum-category | US Core Screening Assessment Observation Maximum Category | trial-use | 3 | cgp | 2024-11 | hl7 | fhir tho |
hl7.fhir.us.core | R4 | us-core-simple-observation-category | US Core Simple Observation Category | trial-use | 3 | cgp | 2024-11 | hl7 | fhir tho |
us.nlm.vsac | R4 | 2.16.840.1.113883.11.20.9.87 | Postpartum Status | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.190123 | Diagnostic Mammography Study | active | 2018-04 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1902 | Ultrasound of the Breast | active | 2019-01 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.190412 | Screening Mammography and DBT Studies | active | 2018-04 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.4066 | Diagnostic DBT Study | active | 2022-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.13883.3.3157.4067 | MRI of the Breast | active | 2024-06 | hl7 | cms | ||
us.nlm.vsac | R4 | 2.16.840.1.13883.3.3157.4068 | MRI of the Breast | active | 2022-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1267.25 | Detailed race including absence reasons. | active | 2025-04 | hl7 | vsac | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.6066 | Ethnic Group (HL7) | active | 2012-01 | tho | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1115.6 | Personal Health Goals LOINC | active | 2024-07 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1115.13 | Healthcare Agent Powers or Limitations Indicator | active | 2024-11 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.208 | Sexual Orientation | active | 2024-04 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.264 | CDS Pregnancy | active | 2024-06 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.265 | CDS Pregnancy Intensional | active | 2024-06 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.11 | Cirrhosis ICD9CM | active | 2024-06 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.13 | Cirrhosis SNOMEDCT | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.14 | Cirrhosis | active | 2024-06 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.179 | Abortion Medications | active | 2024-04 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.184 | Letrozole (Aromatase inhibitor) | active | 2024-04 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1260.12 | Negative | active | 2023-08 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1095.11 | Nutrition Focused Physical Findings SNOMED CT | active | 2025-01 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.207 | PharmacyEnvironmentsOfCare | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.205 | PharmacyTypeOfProfession | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.181 | PharmacyEncounterReason | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.197 | PharmacyAllergies | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.198 | PharmacyInterventions | active | 2024-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.200 | PharmacyReasonsForInterventions | active | 2024-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.201 | PharmacyInterventionStatus | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.202 | PharmacyCareCoordination | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.203 | PharmacyReferralsTo | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.204 | PharmacyGoalStatusOutcome | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.208 | PharmacyEncounterType | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.209 | PharmacytEncounterClass | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.211 | PharmacyAllergyIntoleranceType | active | 2018-09 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.212 | PharmacyAllergyIntoleranceManifestation | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.213 | PharmacyReasonForMedicationChange | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.214 | PharmacyEducation | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.215 | PharmacyEducationStatus | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1096.216 | PharmacyReferralsFrom | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1115.7 | Health Goals Grouping | active | 2022-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.177 | Mifepristone | active | 2024-04 | hl7 | rx | ||
hl7.fhir.us.core | R4 | us-core-screening-assessment-observation-category | US Core Screening Assessment Observation Category | trial-use | 3 | cgp | 2024-11 | hl7 | fhir tho |
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7880 | Education (CO) | active | 2019-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7884 | Exposure Site Category (CO) | active | 2022-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7881 | Generator Location (CO) | active | 2019-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7876 | Intent of Exposure (CO) | active | 2019-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7882 | Generator Distance (CO) | active | 2019-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7878 | Exposure Source (CO) | active | 2019-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7888 | Signs and Symptoms (CO) | active | 2019-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7877 | Extreme Weather Type (CO) | active | 2022-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7891 | Data Reporting Source (CO) | active | 2019-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7887 | Underlying Conditions (CO) | active | 2019-01 | sct tho | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7883 | Person/Organization Taking CO Reading (CO) | active | 2019-01 | tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7886 | Treatment Location (CO) | active | 2019-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7879 | Treatment Type (CO) | active | 2019-01 | sct tho | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.107 | Mechanical Ventilation | active | 2022-05 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.109 | aPTT Tests | active | 2024-06 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1248.106 | Mechanical Ventilation | active | 2024-01 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.96 | Dependence on dialysis | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1166.117 | Syphilis Tests | active | 2023-07 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.20.2.9 | Nutrition Recommendations | active | 2018-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.1.11.15913 | EntityNameUse | active | 2024-06 | hl7 | tho | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7874 | Poison Control Center Record (CO) | active | 2019-01 | sct tho oid | |||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7875 | Workers Compensation Record (CO) | active | 2021-12 | tho oid | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1116.365 | Hospice Care Referral or Admission | active | 2025-05 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.2 | Abdomen CT with contrast | active | 2020-07 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.21 | Abdomen CT Without then With Contrast | active | 2020-07 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1 | Abdomen CT without contrast | active | 2020-07 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1017 | Adrenal Mass | active | 2020-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1020 | Hematuria | active | 2020-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1021 | Infections of Kidney | active | 2020-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1022 | Jaundice | active | 2020-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1023 | Liver Lesion (Mass or Neoplasm) | active | 2020-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1024 | Malignant Neoplasm of Bladder | active | 2020-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1025 | Malignant Neoplasm of Pancreas | active | 2020-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1026 | Non Traumatic Aortic Disease | active | 2023-11 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1028 | Unspecified Disorder of Kidney and Ureter | active | 2020-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1805 | MRI Lumbar Spine Procedures | active | 2020-07 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1802 | Physical Therapy | active | 2020-07 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1812 | Biomechanical Lesions (not Elsewhere Classified) | active | 2020-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1809 | Other Deforming Dorsopathies | active | 2020-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1813 | Dislocation or Sprain of those Joints and Ligaments Located in the Lumbar Spine or Pelvis | active | 2020-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1811 | Other Dorsopathies | active | 2021-04 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1810 | Spondylopathies | active | 2020-07 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.3157.1803 | Chiropractic Evaluation | active | 2020-07 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.13883.3.3157.4069 | Intraspinal Abscess | active | 2022-09 | hl7 | icd | ||
us.cdc.phinvads | R4 | 2.16.840.1.113883.11.20.9.25 | Planned moodCode - Observation (HL7) | active | 2014-12 | tho | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.203 | Intersex Surgery, All | active | 2024-04 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.192 | Infertility, All | active | 2024-04 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1099.59 | Medication Adherence SCT | active | 2024-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1240.8 | Medication Adherence | active | 2023-10 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1078.599 | PIM_Vitamin B12 Level_LOINC_CPT | active | 2023-09 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.1015 | Substance Use | active | 2023-07 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.1016 | Tobacco Use | active | 2024-06 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.1064 | Marital or Spousal Status | active | 2024-06 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.1548 | Cerebrovascular Disease Diagnosis SCT | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.1559 | Metabolic Syndrome Diagnosis SCT | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.1585 | Alcohol Use Related Questionnaire Panel Codes | active | 2024-03 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.1586 | Functional Status Related Questionnaire Panel Codes | active | 2024-05 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.642 | Intracranial Stenosis | active | 2024-06 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.742 | Hypertriglyceridemia | active | 2024-07 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.757 | Restless Leg Syndrome | active | 2024-06 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.807 | Triiodothyronine in serum or plasma | active | 2024-07 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.910 | Abdominal MRI | active | 2024-05 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1222.925 | Foot MRI | active | 2024-07 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.166 | Abortion, Surgical Management | active | 2024-04 | hl7 | cpt | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.167 | Abortion, Surgical Management | active | 2024-04 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.168 | Abortion, Surgical Management | active | 2024-04 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.180 | Contraception, Surveillance | active | 2024-04 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.181 | Contraception, Surveillance | active | 2024-04 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.182 | Contraception, Surveillance | active | 2024-04 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.186 | Infertility, Female | active | 2024-04 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.187 | Infertility, Female | active | 2024-04 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1221.188 | Infertility, Female | active | 2024-04 | hl7 | vsac | ||
us.cdc.phinvads | R4 | 2.16.840.1.114222.4.11.7889 | ICD Codes List (CO) | active | 2019-01 | tho icd | |||
us.cdc.phinvads | R4 | 1.3.6.1.4.1.19376.1.7.3.1.1.23.8.7 | Interventions (HW) | active | 2014-01 | sct | |||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.248 | Suicide Attempt SNOMED CT | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.21 | ALT | active | 2024-06 | hl7 | loinc | ||
hl7.fhir.us.mihr | R4 | PregnancyNonLive | Pregnancy Non-Live | draft | 2023-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1219.193 | Medication Supporting Immunosupressive Medication RxNorm | active | 2022-03 | hl7 | rx | ||
hl7.fhir.us.mihr | R4 | pregnancy | Pregnancy | draft | 2023-03 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1114.14 | Medication drug class for allergen intolerance SCT | active | 2024-06 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1178 | Pervasive Developmental Disorder | active | 2025-03 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.11.1180 | Pervasive Developmental Disorder | active | 2025-03 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.105.12.1152 | Pervasive Developmental Disorder | active | 2024-02 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.464.1003.196.11.1531 | Potentially Harmful Benzodiazepines for Older Adults | active | 2025-01 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.264 | Viral Hemorrhagic Fever (Disorders) (SNOMED) | active | 2024-01 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.265 | Viral Hemorrhagic Fever (Disorders) (ICD10CM) | active | 2024-01 | hl7 | icd | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.581 | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus Nucleic Acid) | active | 2025-02 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.584 | Viral Hemorrhagic Fever (Tests for Viral Hemorrhagic Fever Virus IgG Antibody) | active | 2025-02 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1146.586 | Viral Hemorrhagic Fever (Organism or Substance in Lab Results) | active | 2025-02 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1032.28 | Urine drug screen for pain management | active | 2024-06 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1099.53 | Sex | active | 2024-02 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1099.27 | Care Team Member Function (SNOMEDCT) | active | 2023-07 | hl7 | sct | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1115.21 | Witness Categories | active | 2023-08 | hl7 | loinc | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.3.88.12.80.17 | Medication Clinical General Drug | active | 2024-06 | hl7 | rx | ||
us.nlm.vsac | R4 | 2.16.840.1.113883.4.642.40.2.48.1 | Detailed Ethnicity Including Absence Reasons | active | 2025-04 | hl7 | vsac | ||
us.nlm.vsac | R4 | 2.16.840.1.113762.1.4.1213.111 | Antidepressant Ingredients and Risk of GI Bleeding | active | 2023-12 | hl7 | rx | ||
hl7.fhir.us.vr-common-library | R4 | ValueSet-education-level-person-vr | Value Set - Education Level Person Vital Records | active | pher | 2025-05 | hl7 | loinc | |
hl7.fhir.us.vr-common-library | R4 | ValueSet-input-race-and-ethnicity-person-vr | Value Set - Input Race and Ethnicity Person Vital Records | active | pher | 2025-05 | hl7 | fhir | |
hl7.fhir.us.vr-common-library | R4 | ValueSet-father-relationship-vr | Value Set - Father Relationship Vital Records | active | pher | 2025-05 | hl7 | tho | |
hl7.fhir.us.vr-common-library | R4 | ValueSet-mother-relationship-vr | Value Set - Mother Relationship Vital Records | active | pher | 2025-05 | hl7 | tho | |
hl7.fhir.us.bfdr | R4 | ValueSet-obstetric-procedure-outcome | Obstetric Procedure Outcome | active | pher | 2025-02 | hl7 | sct | |
us.cdc.phinvads | R4 | 2.16.840.1.113883.10.20.15.2.5.6 | Location Relevance (eCR) | active | 2017-01 | oid | |||
hl7.fhir.us.bfdr | R4 | ValueSet-birth-weight-edit-flags | Birth Weight Edit Flags (NCHS) | active | pher | 2025-02 | hl7 | fhir | |
hl7.fhir.us.vr-common-library | R4 | ValueSet-date-of-birth-edit-flags-vr | Value Set - Date of Birth Edit Flags (NCHS) Vital Records | active | pher | 2025-05 | hl7 | fhir | |
hl7.fhir.us.bfdr | R4 | ValueSet-delivery-routes | Delivery Routes | active | pher | 2025-02 | hl7 | sct | |
hl7.fhir.us.bfdr | R4 | ValueSet-estimate-of-gestation-edit-flags | Estimate of Gestation Edit Flags (NCHS) | active | pher | 2025-02 | hl7 | fhir | |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-remains-disposition-method | Fetal Remains Disposition Method | active | pher | 2025-02 | hl7 | sct tho | |
hl7.fhir.us.bfdr | R4 | ValueSet-infections-during-pregnancy-live-birth | Infections During Pregnancy Live Birth | active | pher | 2025-02 | hl7 | sct tho | |
hl7.fhir.us.bfdr | R4 | ValueSet-number-previous-cesareans-edit-flags | Number of Previous Cesareans Edit Flags (NCHS) | active | pher | 2025-02 | hl7 | fhir | |
hl7.fhir.us.vr-common-library | R4 | ValueSet-plurality-edit-flags-vr | Value Set - Plurality Edit Flags (NCHS) Vital Records | active | pher | 2025-05 | hl7 | fhir | |
hl7.fhir.us.bfdr | R4 | ValueSet-pregnancy-report-edit-flags | Pregnancy Report Edit Flags (NCHS) | active | pher | 2025-02 | hl7 | fhir | |
hl7.fhir.us.bfdr | R4 | ValueSet-birth-and-fetal-death-financial-class | Birth and Fetal Death Financial Class | active | pher | 2025-02 | hl7 | ||
hl7.fhir.us.bfdr | R4 | ValueSet-fertility-enhancing-drug-therapy-artificial-insem | Fertility Enhancing Drug Therapy and Artificial Insemination Value Set | active | pher | 2025-02 | hl7 | sct | |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-death-cause-or-condition | Fetal Death Cause or Condition | active | pher | 2025-02 | hl7 | fhir sct tho | |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-death-time-points | Fetal Death Time Points | active | pher | 2025-02 | hl7 | sct tho | |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-presentations-max | Fetal Presentations - Max | active | pher | 2025-02 | hl7 | fhir sct | |
hl7.fhir.us.bfdr | R4 | ValueSet-fetal-presentations | Fetal Presentations | active | pher | 2025-02 | hl7 | sct tho |